Corticosteroids Correct Aberrant CFTR Localization in the Duct and Regenerate Acinar Cells in Autoimmune Pancreatitis

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Ko, Shigeru B H ^a   Mizuno, Nobumasa ^b   Yatabe, Yasushi ^b   Yoshikawa, Toshiyuki ^a   Ishiguro, Hiroshi ^a   Yamamoto, Akiko ^a   Azuma, Sakiko ^a   Naruse, Satoru ^a   Yamao, Kenji ^b   Muallem, Shmuel ^c   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aquaporin Water Channel; CD133; CFTR; Exocrine Function Test

Indexed keywords

CD133 ANTIGEN; IMMUNOGLOBULIN G4; PREDNISOLONE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACINAR CELL; ADULT; AGED; ANTIBODY LABELING; APICAL MEMBRANE; ARTICLE; AUTOIMMUNE PANCREATITIS; CELL REGENERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ENZYME RELEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOADING DRUG DOSE; LONG TERM CARE; MAINTENANCE DRUG DOSE; MALE; PANCREAS DUCT; PANCREAS FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SHORT COURSE THERAPY; TISSUE REPAIR; UPREGULATION;

EID: 77951681488     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.01.001     Document Type: Article

References (36)

1. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 (2001) 732-738
2. Kloppel G., Luttges J., Lohr M., et al. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 27 (2003) 14-19
3. Finkelberg D.L., Sahani D., Deshpande V., et al. Autoimmune pancreatitis. N Engl J Med 355 (2006) 2670-2676
4. - transport in mutations associated with cystic fibrosis. Nature 410 (2001) 94-97
5. - transport in cystic fibrosis. EMBO J 21 (2002) 5662-5672
6. Ishiguro H., Steward M.C., Naruse S., et al. CFTR functions as a bicarbonate channel in pancreatic duct cells. J Gen Physiol 133 (2009) 315-326
7. -. J Biol Chem 279 (2004) 21857-21865
8. - channels with altered pore properties. Nature 362 (1993) 160-164
9. Quinton P.M. Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 79 (1999) S3-S22
10. Kamisawa T., Egawa N., Inokuma S., et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 27 (2003) 235-238
11. Song M.H., Kim M.H., Lee S.K., et al. Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis. Pancreas 30 (2005) 83-86
12. Okazaki K., Kawa S., Kamisawa T., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41 (2006) 626-631
13. Notohara K., Burgart L.J., Yadav D., et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 27 (2003) 1119-1127
14. Mizuno N., Bhatia V., Hosoda W., et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 44 (2009) 742-750
15. Kitagawa M., Naruse S., Ishiguro H., et al. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Pancreas 15 (1997) 402-408
16. Yatabe Y., Koga T., Mitsudomi T., et al. CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas. J Pathol 203 (2004) 645-652
17. Homma T., Harada H., and Koizumi M. Diagnostic criteria for chronic pancreatitis by the Japan Pancreas Society. Pancreas 15 (1997) 14-15
18. Ito T., Nakano I., Koyanagi S., et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 42 (1997) 1458-1468
19. Ko S.B., Naruse S., Kitagawa M., et al. Aquaporins in rat pancreatic interlobular ducts. Am J Physiol 282 (2002) G324-G331
20. Burghardt B., Elkaer M.L., Kwon T.H., et al. Distribution of aquaporin water channels AQP1 and AQP5 in the ductal system of the human pancreas. Gut 52 (2003) 1008-1016
21. Hori Y., Fukumoto M., and Kuroda Y. Enrichment of putative pancreatic progenitor cells from mice by sorting for prominin1 (CD133) and platelet-derived growth factor receptor beta. Stem Cells 26 (2008) 2912-2920
22. Koblas T., Pektorova L., Zacharovova K., et al. Differentiation of CD133-positive pancreatic cells into insulin-producing islet-like cell clusters. Transplant Proc 40 (2008) 415-418
23. Immervoll H., Hoem D., Sakariassen P.Ø., et al. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 8 (2008) 48
24. - secretion: relevance to cystic fibrosis. EMBO J 25 (2006) 5049-5057
25. Schmitt M., Klonowski-Stumpe H., Eckert M., et al. Disruption of paracellular sealing is an early event in acute caerulein-pancreatitis. Pancreas 28 (2004) 181-190
26. Sharer N., Schwarz M., Malone G., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339 (1998) 645-652
27. Cohn J.A., Friedman K.J., Noone P.G., et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339 (1998) 653-658
28. Cohn J.A., Neoptolemos J.P., Feng J., et al. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Hum Mutat 26 (2005) 303-307
29. Ko S.B., Zeng W., Dorwart M.R., et al. Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol 6 (2004) 343-350
30. - secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct. J Clin Invest 119 (2009) 193-202
31. Li C., and Naren A.P. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. Pharmacol Ther 108 (2005) 208-223
32. Forsmark C.E. Chronic pancreatitis. In: Feldman M., Friedman L.S., and Sleisenger M.H. (Eds). Gastrointestinal and liver disease. 7th ed. (2002), Saunders, Philadelphia 943-969
33. Vitali C., Moutsopoulos H.M., and Bombardieri S. The European Community Study Group on diagnostic criteria for Sjogren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis 53 (1994) 637-647
34. Seidler U., Lenzen H., Cinar A., et al. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation. Ann N Y Acad Sci 1072 (2006) 262-275
35. Chmiel J.F., and Konstan M.W. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent. Treat Respir Med 4 (2005) 255-273
36. Auerbach H.S., Williams M., Kirkpatrick J.A., et al. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 28 (1985) 686-688